HeLa, HT1080 human fibrosarcoma cell | Chemical treatment, electroporation | SiRNAs against RAD51 or RAD52 | − | Effective post-transcriptional gene silencing, massive reproductive cell death | 104 |
Breast cancer cell lines (HCC70, HCC1954, and MCF-7) | Gene transfection | let-7a, siRNA against EGFR, anti-EGFR peptide | Breast cancer | Inhibitory impact on the growth of breast cancer tumor model | 105 |
Mouse immature dendritic cells | Gene transfection combined with electroporation | (Lamp2b) fused to αv integrin-specific iRGD peptide, doxorubicin | Breast cancer | Efficient targeting and delivery to tumor cells, suppression of tumor growth without obvious toxicity | 106 |
EL-4 | Incubation at 22 °C for 5 min | Curcumin and cucurbitacin I (Stat3 inhibitor) | GL26 brain tumor model | Prolong the growth of brain tumor, decrease the inflammation in brain, rising microglia cell apoptosis | 107 |
HEK-293T cells | Gene transfection | Cytosine deaminase (CD) fused to uracil phosphoribosyltransferase (UPRT) (suicide gene) | Schwannoma tumors | Inhibition of tumor growth after treatment with modified exosomes accompanied with systematic administration of 5-FC | 108 |
A murine melanoma cell line B16F1 | Cell transduction to the CIITA gene (Class II transactivator) | High amount of MHC class II | Melanoma | Increase the proliferation of splenocyte and IL-2 release; enhance levels of TNF-α, chemokine receptor CCR7, and IL-12; delay tumor growth | 109 |
J558 myeloma cell line | Gene transfection | Texosome contains membrane-bounded HSP70 pulsed with dendritic cells | Melanoma | CTL and NK cell-mediated antitumor responses | 110 |
| Texosome display | Staphylococcal enterotoxin A anchored texosome | Lymphoma | Inhibitory impact on the growth of tumor; increase INF-γ and IL-2; prolong survival time | 99 |
Marrow stromal cell | Transfection | Cel-miR-67 and hsa-miR-146b | 9L gliosarcoma | M146-exo reduce tumor size | 111 |
E.G7-OVA tumor cells | Transfection | Texosome containing IL-2 | E.G7-OVA tumor cells | Induction of antitumor response by Th1 cells, CTL and NK cells, inhibitory effect on tumor growth | 112 |
MCA101 C57Bl/6 fibrosarcoma | Transfection | Tumor antigen bounded to vesicle compared with soluble one | Fibrosarcoma | Inhibitory effect on tumor growth and induction antitumor immune response in bounded manner compared with soluble factor | 113 |
MDA MB-231, MIA PACA-2, SKOV-3 | Exosome display technology | Staphylococcal enterotoxin B anchored tumoral exosome | Breast cancer, pancreatic cancer, ovarian cancer | Induction of apoptosis via intrinsic pathway | 100-102 |
Texosome mimetic | | | | | |
U937cells, Raw 264.7 cells, and CT26 cells | Cell was extruded through 10, 5, and 1 μm filters | Chemotherapeutic drug-loaded texosomes | Colon adenocarcinoma | Dose-dependent TNF-α mediated cell death, inhibitory effect on tumor growth, and induction of antitumor immune responses | 114 |
Embryonic stem cells | Extrusion through microchannels | Native mRNAs of Oct 3/4 and Nanog | NIH-3T3 fibroblasts | An efficient exosome mimetic method to deliver and express mRNA | 115 |